Download | < Back |
07 Feb 2024 | |
Disclosure under Regualtion 30 of the SEBI (Listing Obligations and Disclsoure requirements) Regulations, 2015 - US FDA Inspection at Company''s Riverview Facility. | |
View all announcements for Piramal Pharma Ltd | Source: BSE India |